| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |